BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3490629)

  • 1. Failure to detect any transport of the irreversible monoamine oxidase inhibitor N-cyclopropyl-4-chloroamphetamine by the carrier of 5-hydroxytryptamine in the brain of the rat in vivo.
    Fagervall I; Ross SB
    Neuropharmacology; 1986 Aug; 25(8):911-3. PubMed ID: 3490629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I; Ross SB
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats.
    Ask AL; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):591-6. PubMed ID: 2965308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of monoamine oxidase in 5-hydroxytryptaminergic neurones by substituted p-aminophenylalkylamines.
    Ask AL; Fagervall I; Florvall L; Ross SB; Ytterborn S
    Br J Pharmacol; 1985 Jul; 85(3):683-90. PubMed ID: 3861206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices.
    Ask AL; Fagervall I; Huang RB; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):684-9. PubMed ID: 2770890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition by 4,alpha-dimethyl-m-tyramine (H77/77) and 4-methyl-alpha-ethyl-m-tyramine (H75/12) of the monoamine oxidase within serotonergic and noradrenergic neurons in the rat brain.
    Fagervall I; Kelder D; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):143-7. PubMed ID: 2460774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thiophene analogues of chloroamphetamines on central serotonergic mechanisms.
    Conde S; Madroñero R; Fernández-Tomé MP; del Río J
    J Med Chem; 1978 Sep; 21(9):978-81. PubMed ID: 722762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of monoamine oxidase by p-aminosubstituted phenylalkylamines in catecholaminergic neurones.
    Ask AL; Fagervall I; Florvall L; Ross SB; Ytterborn S
    Neuropharmacology; 1986 Jan; 25(1):33-40. PubMed ID: 3005903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of monoamine oxidase within monoaminergic neurons in the rat brain by (E)-beta-fluoromethylene-m-tyrosine (MDL 72394).
    Fagervall I; Ross SB
    J Neurochem; 1989 Feb; 52(2):467-71. PubMed ID: 2521360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements for uptake into serotoninergic neurones.
    Ross SB; Ask AL
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):270-7. PubMed ID: 7368945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain.
    Ask AL; Fagervall I; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):79-87. PubMed ID: 6646243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
    Gobbi M; Moia M; Pirona L; Ceglia I; Reyes-Parada M; Scorza C; Mennini T
    J Neurochem; 2002 Sep; 82(6):1435-43. PubMed ID: 12354291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine enantiomers as antagonists of p-chloroamphetamine effects in rats.
    Fuller RW; Snoddy HD
    Pharmacol Biochem Behav; 1986 Feb; 24(2):281-4. PubMed ID: 3485293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of the acute and long-term biochemical effects of 4-chloroamphetamine on the 5-HT neurones in the rat brain by inhibitors of the 5-hydroxytryptamine uptake.
    Ross SB
    Acta Pharmacol Toxicol (Copenh); 1976; 39(4):456-76. PubMed ID: 989691
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
    Fattaccini CM; Gozlan H; Hamon M
    Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p-chloroamphetamine and 6-hydroxydopamine in the rat brain.
    Wong DT; Bymaster FP
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):221-31. PubMed ID: 981783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term reduction of brain serotonin by p-chloroamphetamine: effects of inducers and inhibitors of drug metabolism.
    Steranka LR; Sanders-Bush E
    J Pharmacol Exp Ther; 1978 Aug; 206(2):460-7. PubMed ID: 682126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on the effects of N-cyclopropyl-p-chloroamphetamine in rat brain.
    Fuller RW; Perry KW
    Neuropharmacology; 1977; 16(7-8):495-7. PubMed ID: 917253
    [No Abstract]   [Full Text] [Related]  

  • 19. Panuramine, a selective inhibitor of uptake of 5-hydroxytryptamine in the brain of the rat.
    Blurton PA; Broadhurst AM; Cross JA; Ennis C; Wood MD; Wyllie MG
    Neuropharmacology; 1984 Sep; 23(9):1049-52. PubMed ID: 6514142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic effects of isatin: an endogenous MAO inhibitor related to tribulin.
    McIntyre IM; Norman TR
    J Neural Transm Gen Sect; 1990; 79(1-2):35-40. PubMed ID: 1688707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.